Status:
COMPLETED
To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Impotence
Hypertension
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
To assess changes with respect to Erectile Dysfunction in subjects treated with Viagra and antihypertensive therapy.
Eligibility Criteria
Inclusion
- Subjects with arterial hypertension treated with one or more antihypertensive agents, the doses of which have been stable for at least 4 weeks prior to the baseline visit, with a documented clinical diagnosis of ED and a confirmation of this by a qualification of 21 or less on the SHI-M.
Exclusion
- Subjects with resting sitting systolic blood pressure \>170 or \<110mmHg or resting sitting diastolic blood pressure \>90 or \<50mmHg, with significant cardiovascular disease and retinitis pigmentosa, treatment with nitrates, alfablockers or CYP3A4 inhibitors.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT00150358
Start Date
March 1 2005
End Date
November 1 2005
Last Update
February 1 2021
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Torreón, Coahuila, Mexico, 72000
2
Pfizer Investigational Site
Guadalajara, Jalisco, Mexico, 44290
3
Pfizer Investigational Site
Colonia Centro, Mexico City, Mexico, 06090
4
Pfizer Investigational Site
DF, Mexico City, Mexico, 06760